key: cord-0252274-pef09fzg
authors: Hashemian, Seyed Mohammadreza; Jamaati, Hamidreza; Malekmohammad, Majid; Tabarsi, Payam; Khoundabi, Batoul; Shafigh, Navid
title: Efficacy of Early Prone Positioning Combined with Noninvasive Ventilation in COVID-19
date: 2021-02-03
journal: Tanaffos
DOI: nan
sha: 5db23009411ec9b5449c6d2e944714162d23c632
doc_id: 252274
cord_uid: pef09fzg

nan

The role of prone positioning (PP) in the improvement of the oxygenation in patients with acute respiratory distress syndrome (ARDS) is well known. PP contributes to the improvement of the oxygenation by recruitment of collapsed alveoli, redistribution of inflation/ventilation, and by alteration of chest wall elastance (1) . It is mainly recommended and applied in intubated patients with severe ARDS (PaO2/FiO2<100 mmHg) (1, 2) . There is a paucity of data regarding the efficacy of PP in combination with non-invasive ventilation (NIV). Ding L and colleagues recently showed the beneficial role of PP when combined with NIV. They demonstrated the PaO2/FiO2 increased in more than 75% of patients under NIV when PP was applied and the PaO2/FiO2 increment was more significant in severe patients, in whom NIV finally failed (3). Gattinoni et al. suggested the PP might facilitate the oxygenation in COVID-19 patients mainly through redistribution of pulmonary perfusion. Although the data regarding the efficacy of NIV in the setting of ARDS remained still non-conclusive, an early trial of NIV has been suggested to be helpful in selected subpopulation of patients with pneumonia e.g. COVID-19 (5-7).

We prospectively evaluated the efficacy of prone positioning in combination with NIV therapy in COVID-19 patients admitted to our intensive care unit (ICU) wards at Massih Daneshvari Hospital from 26 February to 25 April 2020. The COVID-19 patients with a body mass index (BMI) less than 18 or greater than 30 and those requiring emergent intubation or already intubated have been excluded from the study. A random allocation sequence was generated. The patients were assigned by head nurse to one of the treatment groups; the NIV or NIV+PP groups. However, PaO2/FiO2 significantly increased in all three subgroups of patients who received NIV in combination with PP ( Figure 1 ). Although the mean of the SpO2 and PaO2/FiO2 does not show significant difference among patients with severe ARDS in NIV and NIV+PP groups at admission, this measure showed a significant difference 24 hours after ICU admission (p=0.003). In addition, the application of NIV combined with PP resulted in a significantly shorter length of ICU admission (8.6 vs. 14.4, p=0.046). The need for intubation (22% vs. 40%, p=0.082) and the rate of mortality (20% vs. 33%, p=0.152) were though lower in the NIV+PP group, and failed to reach the statistical significance (Table 2) .

To the best of our knowledge, this is the first study evaluating the role of PP in combination with NIV in COVID-19. The presented results are strongly in favor of the use of PP in combination with NIV in critically ill patients with COVID-19, especially those with severe ARDS. The application of simple non-costly treatment approaches e.g. PP at the time of pandemics are of special importance, as pandemics usually result in overuse of ICU beds and strain on available resources. 

Prone Positioning in Acute Respiratory Distress Syndrome

A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study

Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study

COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome

Management of COVID-19 Respiratory Distress

Noninvasive Versus Invasive Ventilation in COVID-19: One Size Does Not Fit All!

The Bumpy Road for Noninvasive Ventilation in Acute Respiratory Distress Syndrome. Coming to an End?